Symbol="MGTA"
AssetType="Common Stock"
Name="Magenta Therapeutics Inc"
Description="Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel drugs to bring the healing power of stem cell transplantation, gene therapy, genome editing, and cell therapy to patients. The company is headquartered in Cambridge, Massachusetts."
CIK="1690585"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="47015100"
EBITDA="-57211000"
PERatio="None"
PEGRatio="None"
BookValue="1.236"
DividendPerShare="0"
DividendYield="0"
EPS="-1.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.288"
ReturnOnEquityTTM="-0.653"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.537"
EVToRevenue="-"
EVToEBITDA="0.399"
Beta="2.119"
num_52WeekHigh="2.22"
num_52WeekLow="0.32"
num_50DayMovingAverage="0.761"
num_200DayMovingAverage="0.79"
SharesOutstanding="60665000"
DividendDate="None"
ExDividendDate="None"
symbol="MGTA"
open="0.76"
high="0.77"
low="0.75"
price="0.76"
volume="156077.00"
latest_trading_day="2023-08-22"
previous_close="0.78"
change="-0.01"
change_percent="-1.9355%"
aroon_positive_momentum_days="53"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="423146"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="499"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="965"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_positive_thumbnail_id_2="677"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0031.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
